Pirola [80] demonstrated, via Ago2 complex immunoprecipitation, that only a small fraction of circulating miR-122 is Ago2 bound in human NAFLD serum, but did not identify EVs as the alternative source. This evidence concerns the gene AGO2 and metabolic dysfunction-associated steatotic liver disease.